Biden Plans Federal-Private Consortia To Steer Drug Supply Chain Plan

The White House has asked HHS to lead a consortium comprising nearly a dozen federal agencies, the private sector and nonprofit entities charged with crafting a strategy to secure the pharmaceutical supply chain by boosting U.S. production, developing new manufacturing technologies, and increasing the resilience of U.S. and allied pharmaceutical production. The White House will kick off the effort with a high-level summit, according to a supply chain report released by the White House this week . The new consortium...